Research Article

Role of Transforming Growth Factor-β1 and Smads Signaling Pathway in Intrauterine Adhesion

Table 4

Clinical and laboratory findings of the study groups.

Variable IUA () Control ()

Clinical findings
Age 28.06 ± 3.63 28.43 ± 3.440.319
Normal menses 30 0
Hypomenorrhea 600
Cyclical lower abdominal pain 240
Abortion 60 0
Laboratory findings
RBC (1012/L)4.41 ± 0.284.42 ± 0.210.948
WBC (109/L)5.38 ± 1.335.47 ± 0.830.748
Hb (g/L)131.5 ± 7.79133.13 ± 6.140.089
FSH (mlU/mL)7.58 ± 1.768.18 ± 1.530.117
LH (mlU/mL)7.64 ± 2.447.68 ± 1.670.209
PRL (ng/mL)17.59 ± 2.9516.57 ± 3.860.168
Estrogen (pmol/L)277.25 ± 155.4282.65 ± 121.910.868
Progesterone (0.ng/mL)0.651 ± 1,020.822 ± 0.070.366
Testosterone (ng/dL)28.76 ± 7.6128.42 ± 5.820.831

The data are represented as mean ± SD. FSH = follicle stimulating hormone, LH = luteinizing hormone, and PRL = prolactin. All values are represented comparisons between IUA patient and control groups.